Supplement: The Association Between Stigma and Wellbeing among Kaposi sarcoma and Lymphoma Patients in Malawi

补充：马拉维卡波西肉瘤和淋巴瘤患者的耻辱与健康之间的关系

• 批准号: 10844951
• 负责人: BLOSSOM A DAMANIA
• 金额: $ 17.22万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-13 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10844951
• 关键词: AIDS Malignancy Consortium; AIDS clinical trial group; AIDS related cancer; AIDS-Related Lymphoma; Achievement; Acquired Immunodeficiency Syndrome; Address; Adult; Africa; Africa South of the Sahara; African; Award; Biological Markers; Biopsy; Cancer Hospital; Cancer Patient; Caring; Characteristics; Clinical; Clinical Research; Clinical Trials; Collaborations; Communicable Diseases; Comprehensive Cancer Center; Continuity of Patient Care; Crystallization; Data; Eligibility Determination; Enrollment; Epidemic; Flowers; Future; Goals; Grant; HIV; Health; Hospitals; Individual; Institution; International; Intervention; Kaposi Sarcoma; Knowledge; Lead; Leadership; Lymphoma; Malawi; Malignant Neoplasms; Malignant neoplasm of cervix uteri; Measures; Medicine; Mental Health; Molecular; Morbidity - disease rate; Newly Diagnosed; North Carolina; Outcome; Parents; Patient-Focused Outcomes; Patients; Personal Satisfaction; Persons; Policies; Positioning Attribute; Prevalence; Prognosis; Qualifying; Qualitative Research; Quality of life; Recurrence; Research; Research Infrastructure; Research Personnel; Research Project Grants; Science; Site; South Africa; Surveys; Survival Rate; Training; Training and Infrastructure; Translational Research; Trust; UNC Lineberger Comprehensive Cancer Center; United States National Institutes of Health; Universities; anticancer research; cancer care; career; clinical research site; cohort; college; combat; data sharing; detection method; experience; global health; high risk; improved; innovation; insight; interest; internalized stigma; intersectionality; low and middle-income countries; mortality; next generation; oncology program; programs; progression risk; prospective; resilience; response; screening; social stigma; translational impact; treatment and outcome; tumor

ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 23-036. Stigma hampers the cancer care continuum, leading to delayed presentation to care, elevated morbidity and mortality, and reduced quality of life, particularly for patients with HIV-associated cancers. Qualitative research has elucidated the lived experience of stigma among cancer patients and the adverse impact of this stigma on mental health, self-isolation and engagement in care. However, there remains a gap in quantifying the prevalence and distribution of cancer-related stigma and its impact on health-related outcomes for patients with HIV-associated cancers. In response, we are currently developing and validating measures of enacted, anticipated, internalized stigma in Malawi (P30CA042014-33S5, Lead Kimani). With this supplement, the overall goal is to embed these new cancer stigma measures in existing cohorts of cancer patients in Malawi in order to better understand the prevalence and impact of cancer stigma in an African public cancer hospital. Our long-term goal is to use the results from this study to develop R01-level grants for targeted, multi-level interventions to address cancer stigma in Africa and ultimately improve cancer outcomes. In this proposed supplement, we will build on the parent award (U54CA254564, PI Damania) by leveraging the U54 prospective Kaposi sarcoma (KS) and lymphoma cohorts to explore the experience of cancer-related stigma, its impact on clinical outcomes, and its intersection with HIV stigma. Specifically, we will survey newly diagnosed adult patients with biopsy-proven KS or lymphoma, who are receiving or eligible for active cancer care, and enrolled in the parent study to measure cancer and HIV stigma and abstract cancer and patient data from the U54 routine study assessments. We will then quantify the prevalence of cancer stigma among KS and lymphoma patients in Malawi (Aim 1). We will additionally identify key cancer (characteristics, treatment and outcomes) and patient (quality of life, mental health, resilience) factors correlated with cancer stigma, and assess the intersectionality of HIV and cancer stigma (Aim 2). Ultimately, this innovative research will generate findings that will stimulate and strengthen global cancer stigma, build local capacity to conduct cancer stigma research, and lay the ground-work for future R01 proposals to implement and evaluated multi-level interventions that address cancer stigma in Africa and ultimately improve cancer care and outcomes.

抽象的 本申请是为了响应被识别为 NOT-CA- 的特殊利益通知 (NOSI) 而提交的 23-036。耻辱阻碍了癌症护理的连续性，导致延迟就诊，增加 发病率和死亡率以及生活质量下降，特别是对于患有艾滋病毒相关癌症的患者。 定性研究阐明了癌症患者耻辱感的生活经历及其不利影响 这种耻辱对心理健康、自我隔离和参与护理的影响。但仍存在差距 量化癌症相关耻辱的患病率和分布及其对健康相关结果的影响 对于患有艾滋病毒相关癌症的患者。为此，我们目前正在制定和验证以下措施： 马拉维实施的、预期的、内在的耻辱（P30CA042014-33S5，Kimani 负责人）。有了这个补充， 总体目标是将这些新的癌症耻辱措施纳入马拉维现有的癌症患者群体中 为了更好地了解非洲公立癌症医院中​​癌症耻辱的普遍程度和影响。 我们的长期目标是利用本研究的结果为有针对性的多层次项目开发 R01 级资助 旨在解决非洲癌症耻辱感并最终改善癌症结果的干预措施。在这个提议中 补充，我们将利用 U54 的前景，以家长奖（U54CA254564，PI Damania）为基础 卡波西肉瘤（KS）和淋巴瘤队列探讨癌症相关耻辱的经历及其对 临床结果及其与艾滋病毒耻辱的交叉点。具体来说，我们将调查新诊断的成人 经活检证实患有 KS 或淋巴瘤、正在接受或有资格接受积极癌症治疗并已入组的患者 在母研究中衡量癌症和艾滋病毒耻辱并从 U54 中​​提取癌症和患者数据 常规学习评估。然后我们将量化 KS 和淋巴瘤中癌症耻辱感的患病率 马拉维的患者（目标 1）。我们还将确定关键癌症（特征、治疗和结果） 以及与癌症耻辱感相关的患者（生活质量、心理健康、复原力）因素，并评估 HIV 和癌症耻辱的交叉性（目标 2）。最终，这项创新研究将产生结果 这将刺激和加强全球癌症耻辱感，建设当地开展癌症耻辱感研究的能力， 并为未来 R01 提案实施和评估多层次干预措施奠定基础 解决非洲癌症耻辱问题并最终改善癌症护理和结果。

项目成果

Impact of Antiretroviral Therapy on Cancer Treatment Outcomes among People Living with HIV in Low- and Middle-Income Countries: a Systematic Review.

• DOI: 10.1007/s11904-021-00542-5
• 发表时间: 2021-04
• 期刊: Current HIV/AIDS reports
• 影响因子: 4.6

Update on pathology laboratory development and research in advancing regional cancer care in Malawi.

• DOI: 10.3389/fmed.2024.1336861
• 发表时间: 2024
• 期刊: FRONTIERS IN MEDICINE
• 影响因子: 3.9
• 作者: Brownlee, Amy J.;Dewey, Morgan;Chagomerana, Maganizo B.;Tomoka, Tamiwe;Mulenga, Maurice;Khan, Shiraz;Kampani, Coxcilly;Chimzimu, Fred;Gastier-Foster, Julie M.;Westmoreland, Kate D.;Ozuah, Nmazuo W.;Krysiak, Robert;Malamba-Banda, Chikondi;Painschab, Matthew S.;Gopal, Satish;Fedoriw, Yuri
• 通讯作者: Fedoriw, Yuri

Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi.

病例报告：多中心卡斯尔曼病是马拉维免疫重建炎症综合征的一种表现。

• DOI: 10.3389/fonc.2022.969135
• 发表时间: 2022
• 期刊: Frontiers in oncology
• 影响因子: 4.7

The role of telepathology in improving cancer diagnostic and research capacity in sub-Saharan Africa.

• DOI: 10.3389/fmed.2022.978245
• 发表时间: 2022
• 期刊: Frontiers in medicine
• 影响因子: 3.9

Letters to the Editor Low Rates of Side Effects in Paclitaxel Chemotherapy for Kaposi Sarcoma and Feasibility of Treatment in Outpatient ART Clinic Settings in Malawi.

致编辑的信 紫杉醇化疗卡波西肉瘤的副作用发生率低，以及马拉维门诊 ART 诊所治疗的可行性。

• DOI: 10.1097/qai.0000000000003393
• 发表时间: 2024
• 期刊: Journal of acquired immune deficiency syndromes (1999)
• 作者: Rambiki,Ethel;Rambiki,Kelvin;Khalani,Jennipher;Huwa,Jacquiline;Wallrauch,Claudia;Heller,Tom;Painschab,Matthew
• 通讯作者: Painschab,Matthew